Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity

Human Immunology

Volumn 59, Issue 3, 1998, Pages 176-182

  Djilali Saiah, Idriss ^a   Bertin, Eric ^a,b   Larger, Etienne ^c   Timsit, José ^a   Assan, Roger ^c   Boitard, Christian ^a   Bach, Jean François ^a   Caillat Zucman, Sophie ^a  

^a INSERM   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; THYROID DISEASE; TRANSGENE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENES, MHC CLASS II; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SEX FACTORS; THYROID DISEASES;

EID: 0031916396     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00002-0     Document Type: Article

References (60)

1. Eisenbarth GS. Type I diabetes mellitus A chronic autoimmune disease . N Engl J Med. 314:1986;1360-1368.
2. Rotter JI, Rimoin DL. Heterogeneity in diabetes mellitus, update 1978 evidence for further genetic heterogeneity within juvenile-onset insulin dependent diabetes mellitus . Diabetes. 27:1978;599-608.
3. Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M. A comparison of childhood and adult type I diabetes mellitus. N Engl J Med. 320:1989;881-886.
4. Riley WJ, Toskes PP, Maclaren NK, Silverstein JH. Predictive value of gastric parietal cell auto-antibodies as a marker for gastric and hematologic abnormality with insulin dependent diabetes. Diabetes. 31:1982;1051-1055.
5. Betterle C, Zanette F, Presotto F, Rapp LB, Monciotti CM, Rigon F. Clinical and subclinical organ-specific auto-immune manifestations in type1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia. 26:1984;431-436.
6. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetotologia. 30:1987;132-143.
7. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type1 (insulin-dependent) diabetes mellitus in Sweden during one year and matched control children. Diabetologia. 32:1989;387-395.
8. Bottazzo GF, Doniach D. Pancreatic autoimmunity and HLA antigens. Lancet. 2:1976;800.
9. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A10-year follow-up study. Diabetologia. 30:1987;292-297.
10. Betterle C, Presotto F, Magrin L, Pedini B, Moro L, Caretto A, Zanchetta R. The natural history of pre-Type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases. Diabetologia. 37:1994;95-103.
11. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with auto-immune polyendocrine deficiencies. Lancet. 2:1974;1279-1283.
12. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes. 35:1986;237-241.
13. Irvine WJ, McCallum CJ, Gray RS. Pancreatic islet-cell antibodies in diabetes mellitus correlates with the duration of type 1 diabetes, coexistent autoimmune disease and HLA type. Diabetes. 26:1977;138-147.
14. Leiter E, Prochaska M, Collemean D. The non obese diabetic (NOD) mouse. Am J Pathol. 128:1987;380-383.
15. Sternthal E, Like A, Sarantis K, Braverman L. Lymphatic thyroiditis and diabetes in the BB/w rat. Diabetes. 30:1981;1058-1061.
16. Sakaguchi N, Miyai K, Sakaguchi S. Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression. J Immunol. 152:1994;1471-1484.
17. Fowell D, Masson D. Evidence that the cell repertoire of normal rats contains cells with the potential to cause diabetes-caracterization of the CD4+ T cells subset that inhibits this auto-immune potential. J Exp Med. 177:1993;627-636.
18. Thomson G, Robinson WP, Kuhner MK, Joe S, Macdonald MJ, Gottschall JL, Barbosa J, Rich SS, Bertrams J, Baur MP, Partanen J, Tait BD, Schober E, Mayr WR, Ludvigsson, Lindblom JB, Farid R, Thompson C, Deschamps I. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 43:1988;799-816.
19. Bertrams J, Baur MP: Insulin-dependent diabetes mellitus. In Albert ED, Baur MP and Mayr WR (eds): Histocompatibility testing 1984: report on the ninth international histocompatibility workshop and conference held in Munich, West Germany, May 1984 and in Vienna, Austria, May 1984. Berlin: Springer-Verlag. 348-358, 1984.
20. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 322:1990;1836-1841.
21. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;371-377.
22. Todd JA, Bell JI, McDevitt HO. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599-604.
23. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, Bach JF. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest. 90:1992;2242-2250.
24. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, Beshkov Y, Costin G, Pressman S, Bugawan T, Rotte JI. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genet. 3:1993;358-364.
25. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters. Nature. 348:1990;741-743.
26. Monaco J, Cho S, Attaya M. Transport protein genes in the murine MHC possible implications for antigen processing . Science. 250:1990;1723-1726.
27. Bahram S, Arnold D, Bresnahan M, Strominger J, Spies T. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II. Proc Natl Acad Sci USA. 88:1991;10094-10098.
28. Powis S, Mockridge I, Kelly A, Kerr LA, Glynne R, Gileadi U, Beck S, Trowsdale J. Polymorphism in a second ABC transporter gene located within the Class II region of the human major histocompatibility complex. Proc Natl Acad Sci USA. 89:1992;1465-1467.
29. Colonna M, Bresnahan M, Bahram S, Strominger J, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA. 89:1992;3932-3936.
30. Ronningen KS, Undlien D, Ploski R, Maouni N, Konrad R, Hornes E, Reijonen H, Colonna M, Monos D, Strominger J, Thorsby E. Linkage disequilibrium between TAP2 variants and HLA class II alleles no primary association between TAP2 variants and insulin-dependent diabetes mellitus . Eur J Immunol. 23:1993;1050-1056.
31. Van Endert P, Liblau R, Fugger L, Pocio TF, Nerup J, McDevitt H. MHC-encoded antigen processing gene polymorphism in type1 diabetes. Diabetes. 43:1994;110-117.
32. Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes Absence of contribution to association with insulin dependent diabetes mellitus . Human Immunol. 44:1995;80-87.
33. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 29:1979;1039-1057.
34. Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF. Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia. 33:1990;731-736.
35. Harfouch-Hammoud E, Timsit J, Boitard C, Bach JF, Caillat-Zucman S. Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of DQ. J Autoimmunity. 9:1996;411-414.
36. Undlien DE, Friede T, Rammensee HG, Joner G, Dahl-Jorgensen K, Sovik O, Akselsen H, Knutsen I, Ronningen K, Thorsby E. HLA-encoded genetic predisposition in IDDM DR4 subtypes may be associated with different degrees of protection . Diabetes. 46:1997;143-149.
37. Caillat-Zucman S, Djilali-Saiah I, Timsit J, Bonifacio E, Sepe V, Collins P, Bottazzo GF, Maclaren N, Delamaire M, Martin S, Yamamoto AM, McWeeney S, Valdes AM, Babron MC, Thorsby E, Clerget-Darpoux F, Thomson G, Bach JF, and the participating centers: Insulin dependent diabetes (IDDM): 12th International Histocompatibility Workshop Study (pp. 389-398). In Charron D, (ed): HLA: Genetic diversity of HLA. Functional and medical implication. Paris, EDK International, 1997.
38. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS. HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type1 diabetic patients. J Clin Endocrinol Metab. 78:1994;878-883.
39. Huang W, Connor E, Dela Rosa T, Muir A, Schatz D, Silverstein J, Crocket S, She JX, Maclaren NK. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the Human Leukocyte Antigen DR4-DQB1*0302 haplotype is implicated only in β-cell autoimmunity. J Clin Endocrinol Metab. 81:1996;2559-2563.
40. Maugendre D, Alizadeh M, Gauthier A, Guilhem I, Pouillaud C, Genetet B, Allannic H, Semana G. Genetic heterogeneity between type 1a and type 1b insulin-dependent diabetes mellitus HLA class II and TAP gene analysis . Tissue Antigens. 48:1996;540-548.
41. Tait B, Harrison L, Drummond B, Stewart V, Varney M, Honeyman M. HLA antigens and age at diagnosis of insulin dependent diabetes mellitus. Human Immunol. 42:1995;116-122.
42. Kwok WW, Nepom GT, Raymond FC. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol. 155:1995;2468-2476.
43. Hammer J, Gallazzi F, Bono E, Karr R, Guenot JM, Valsasnini P, Nagy Z, Sinigaglia F. Peptide binding specificity of HLA-DR4 molecules correlation with rheumatoid arthritis association . J Exp Med. 181:1995;1847-1855.
44. Farid N, Thompson C. HLA and autoimmune endocrine disease 1985. Mol Biol Med. 3:1986;85-97.
45. Eisenbarth G, Wilson P, Ward F, Lebovitz H. HLA type and occurence of disease in familial polyglandular failure. New Engl J Med. 298:1978;92-294.
46. Maclaren NK, Riley WJ. Inherited susceptibility to autoimmune in Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type1 autoimmune polyglandular syndrome. J Clin Endocrinol Metab. 62:1986;455-461.
47. Payami H, Joe S, Thomson G. Autoimmune thyroid disease in type 1 diabetic families. Genet Epidemiol. 6:1989;137-141.
48. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach JF, Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology. 129:1991;1382-1390.
49. Fox H. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med. 175:1992;1409-1412.
50. Lahita R. Hormones, genes and Autoimmunity. Farid N. The Immunogenetics of autoimmune diseases, Vol. 1. 1991;67-80 CRC Press.
51. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA. A genome-wide search for human type1 diabetes susceptibility genes. Nature. 371:1994;130-136.
52. Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop M, Julier C. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature. 371:1994;161-164.
53. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, Nerup J, Bouzekri N, Cambon-Thomson A, Ronningen KS, Barnett AH, Bain SC, Todd JA. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet. 9:1995;284-292.
54. Copeman JB, Cucca F, Hearne CM, Cornall RJ, Reed PW, Ronningen KS, Undlien DE, Nistico L, Buzzetti R, Tosi R, Pociot F, Nerup J, Cornelis F, Barnett AH, Bain SC, Todd JA. Linkage disequilibrium mapping of type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-33. Nature Genet. 9:1995;80-85.
55. Pociot F, Ronningen KS, Bergholdt R, Lorenzen T, Johannesen J, Ye K, Dinarello CA, Nerup J. Genetic susceptibility markers in Danish patients with type 1 (insulin dependent) diabetes - Evidence for polygenecity in man. Autoimmunity. 19:1994;169-178.
56. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lathrop M, Pressey A, Delarato NH, Peterson LB, Wicker LS. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 351:1991;542-546.
57. Wicker LS, Appel MC, Dotta F, Pressey A, Miller BJ, DeLarato NH, Fischer PA, Boltz RC Jr, Peterson LB. Autoimmune syndrome in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes . J Exp Med. 176:1992;67-77.
58. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, De Groot J. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 80:1995;41-45.
59. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vanderwall CL, Schuit F, Gorus FK, Tosi R, Pozzili P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet. 5:1996;1075-1080.
60. Donner H, Rau H, Walfich PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA-4 Alanine confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab. 82:1997;143-146.